U.S. Food and Drug Administration, Center for Drug Evaluation and Research
20 episodes
9 months ago
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.
All content for Q&A with FDA is the property of U.S. Food and Drug Administration, Center for Drug Evaluation and Research and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.
Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim
Q&A with FDA
12 minutes 13 seconds
1 year ago
Switching Between Biosimilars and Their Reference Counterparts with Dr. Sarah Yim
Q&A with FDA
"Q&A with FDA" provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA.
